Ezetimibe 10 mg in the Philippines
Quick answer
There is no DOH reference price for Ezetimibe 10 mg; FDA Philippines lists 11 registered products at Ezetimibe 10 mg (checked 2026-11-05): 11 under 10 brand names. It is a prescription (Rx) medicine. No unbranded generic is registered, so ask for the cheapest brand with the same generic name and strength; it is on the FDA VAT-exempt list, so no 12% VAT applies.
Registered products
Registered Ezetimibe 10 mg products
FDA Philippines lists 11 registrations under 10 brand names.
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Exelzio | 10 mg Tablet | Rx | KRKA, d.d., Novo Mesto (Slovenia) | 1 |
| EzeGet | 10 mg Tablet | Rx | Hetero Labs Limited (Unit III) (India) | 1 |
| Ezemibe | 10 mg tablet | Rx | Medisure Laborartories Pakistan (Pvt.) Ltd. (Pakistan) | 1 |
| Ezetrol | 10 mg Tablet; 10mg Tablet | Rx | MSD International GmbH (Puerto Rico Branch) LLC (USA) +1 more | 2 |
| Ezgen | 10 mg Tablet | Rx | Lloyd Laboratories Inc. (Philippines) | 1 |
| Ezidril | 10 mg Tablet | Rx | Lloyd Laboratories Inc. (Philippines) | 1 |
| Ezitin | 10 mg Tablet | Rx | Hetero Labs Limited (India) | 1 |
| Ledipsa | 10 mg tablet | Rx | Lupin Limited - Unit 2 (India) | 1 |
| Saphzettige10 | 10 mg Tablet | Rx | Genom Biotech Pvt. Ltd. (India) | 1 |
| Zetlow-10 | 10 mg Tablet | Rx | Hetero Labs Limited (Unit III) (India) | 1 |
Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.
Ezetimibe 10 mg: products and brands
Paying less for ezetimibe
- Ask for the generic
Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works
- Senior or PWD card
20% off plus no VAT on your own medicines, with ID and prescription. What to bring
- No VAT on this one
It is on the FDA VAT-exempt list, so the 12% VAT should not be on your receipt. The list
Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.